oxybutynin chloride extended release oxybutynin chloride tablet extended release
1 INDICATIONS AND USAGE Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ( 1 ) Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). ( 1 )
rising pharmaceuticals, inc.
ROUND PINK P 10
P 10 ROUND PINK
Related Pills
loratadine 10 mg
spirit pharmaceuticals llc
24 HR Glipizide 10 MG Extended Release Oral Tablet
Rising Pharmaceuticals, Inc.
24 HR Glipizide 10 MG Extended Release Oral Tablet
Rising Pharmaceuticals, Inc.
loratadine 10 mg
spirit pharmaceuticals llc
propranolol 10 mg
dispensing solutions, inc.
acetazolamide 500 MG 12 HR Extended Release Capsule
Zydus Pharmaceuticals (USA) Inc.
gabapentin 100 MG Oral Capsule
AvKARE, Inc.
gabapentin 300 MG Oral Capsule
AvKARE, Inc.
APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet
Rebel Distributors Corp
APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet
American Health Packaging
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
OXYBUTYNIN CHLORIDE extended-release tablets USP are available in three dosage strengths, 5 mg (pale yellow round biconvex with orifice), 10 mg (pink round biconvex with orifice), and 15 mg (grey round biconvex with orifice) and are imprinted on one side with "P 5", "P 10", or "P 15" with black ink.
OXYBUTYNIN CHLORIDE extended-release tablets USP are supplied in bottles of 30, 100 and 500 tablets. 5 mg 30 count bottle NDC 64980-209-03 5 mg 100 count bottle NDC 64980-209-01 5 mg 500 count bottle NDC 64980-209-05 10 mg 100 count bottle NDC 64980-210-01 10 mg 500 count bottle NDC 64980-210-05 15 mg 100 count bottle NDC 64980-211-01 15 mg 500 count bottle NDC 64980-211-05 Storage Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [see USP Controlled Room Temperature]. Protect from moisture and humidity. Keep out of reach of children.
More pills like ROUND P 10